(Thanks to Atid-EDI) Israel’s Kadimastem is to work with giant Merck to conduct screening for new treatments into Multiple Sclerosis and other neurodegenerative diseases. Kadimastem’s revolutionary technology uses stem cells to produce cells that protect or repair brain function.
http://www.kadimastem.com/press-item/60/kadimastem-to-collaborate-merck-serono-advance-combined-efforts-in-neurodegenerative-disease-area